✦ LIBER ✦

Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts

✍ Scribed by Andreas Mackensen; Hendrik Veelken; Michael Lahn; Sebastian Wittnebel; Daniel Becker; Gabriele Köhler; Peter Kulmburg; Ulrich Brennscheidt; Felicia Rosenthal; Brigitte Franke; Roland Mertelsmann; A. Lindemann

Publisher: Springer
Year: 1997
Tongue: English
Weight: 355 KB
Volume: 75
Category: Article
ISSN: 0946-2716
DOI: 10.1007/s001090050114

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of tumor-specific cytotoxic T

Induction of tumor-specific cytotoxic T lymphocytes and natural killer cells by tumor cells transfected with the interleukin-2 gene

✍ Yoshimi Iwanuma; Kazunori Kato; Hideo Yagita; Ko Okumura 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 743 KB

Induction of human glioma-specific cytot

Induction of human glioma-specific cytotoxic T-lymphocyte lines by autologous tumor stimulation and interleukin 2

✍ Shinichi Miyatake; Hajime Handa; Junkoh Yamashita; Toshiki Yamasaki; Masamichi U 📂 Article 📅 1986 🏛 Springer US 🌐 English ⚖ 817 KB

Induction and clonal expansion of tumor-

Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells

✍ Toshiro Kurokawa; Mathias Oelke; Andreas Mackensen 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 189 KB 👁 2 views

Induction of autologous tumor-specific c

Induction of autologous tumor-specific cytotoxic T cells in patients with liver cancer. Characterizations and clinical utilization

✍ Atsushi Aruga; Katsumi Yamauchi; Ken Takasaki; Takaji Furukawa; Fujio Hanyu 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 838 KB

Effectoritarget ratio.AJsually 5'Cr release assays were performed for 4 hr except in Exp. 6, which was for 18 hr.-The data are means \* standard deviation of triplicate determinations.

Generation of tumor-specific cytotoxic T

Generation of tumor-specific cytotoxic T lymphocytesin vivoby combined treatment with inactivated tumor cells and recombinant interleukin-2

✍ Mamoru Harada; Goro Matsuzaki; Yoshihiro Shinomiya; Shin Kurosawa; Osamu Ito; Ta 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 717 KB

A phase-I clinical study of autologous t

A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer

✍ Hendrik Veelken; Andreas Mackensen; Michael Lahn; Gabriele Köhler; Daniel Becker 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 257 KB 👁 2 views

Tumor cells transfected to express immunostimulatory cytokines, or admixed with similarly modified bystander cells, are able to induce immune responses against unmodified tumor cells in animal models. For treatment of human patients, a vaccine composed of autologous tumor cells and IL-2-secreting al